Seeking Alpha

Complete Genomics, Inc. (GNOM)

GNOM is defunct.
  • May 8, 2012, 3:57 PM
    Complete Genomics (GNOM -16%) drops hard after missing on its Q1 late yesterday on wider-than-expected losses. Revenue was down 42% Y/Y, largely due to an unexpected revenue recognition deferral for 200 units previously sold into Q2.
    | May 8, 2012, 3:57 PM | Comment!
  • Mar. 8, 2012, 6:25 PM
    Complete Genomics (GNOM) reverses late session gains to trade lower in the post session after reporting a Q4 loss of $0.67 per share, compared with the prior-year period's $0.69 loss per share. Revenues were $2.5M, down 34% from $3.8M in the same quarter last year. The Street was expecting a loss of $0.65 on revenues of $3.15M. Shares -2.1% AH.
    | Mar. 8, 2012, 6:25 PM | Comment!
Company Description
Currently, there's no company description for GNOM.
Sector: Healthcare
Industry: Biotechnology
Country: United States